Leonard B, Bies R, Carlson T, Reeve E B
Thromb Res. 1983 Apr 15;30(2):165-77. doi: 10.1016/0049-3848(83)90239-6.
Fresh plasma containing 131I-antithrombin III (*I-AT) was coagulated and incubated at 37 degrees C for 2 hr. A "complex peak," separated on heparin-agarose contained AT and *I-AT antigen but no heparin cofactor activity. Crossed immunoelectrophoresis showed only AT complexes. SDS PAGE showed 80% of the *I-AT in a major band (approximately 80,000 daltons), 15% in a minor band (approximately 100,000 daltons) and the rest in trace bands (approximately 60,000 and/or 115,000 daltons). Ammonia treatment of the complex peak released alpha-thrombin. After i.v. injection 80% of the complexed *I-AT, chiefly as the major band, left the plasma with t 1/2 approximately 15 min and was almost immediately catabolized to low molecular weight breakdown products. A major catabolic site was the liver. A simple kinetic model describes the findings approximately.
含有131I - 抗凝血酶III(I - AT)的新鲜血浆被凝固并在37℃孵育2小时。在肝素 - 琼脂糖上分离出的一个“复合物峰”含有抗凝血酶(AT)和I - AT抗原,但没有肝素辅因子活性。交叉免疫电泳仅显示出AT复合物。十二烷基硫酸钠 - 聚丙烯酰胺凝胶电泳(SDS PAGE)显示,80%的I - AT在一条主要条带中(约80,000道尔顿),15%在一条次要条带中(约100,000道尔顿),其余在微量条带中(约60,000和/或115,000道尔顿)。对复合物峰进行氨处理可释放出α - 凝血酶。静脉注射后,80%的复合I - AT(主要为主要条带形式)离开血浆,半衰期约为15分钟,几乎立即被分解为低分子量的分解产物。主要的分解部位是肝脏。一个简单的动力学模型大致描述了这些发现。